Cramer's Morning Take: Bristol Myers & Eli Lilly 11/25/24
Squawk on the Street
00:00
Analyzing Pharmaceutical Financial Projections and Market Dynamics
This chapter analyzes the financial growth potential for companies like Bristol Myers and Eli Lilly in the pharmaceutical sector. It highlights expected revenue increases from new drug approvals while addressing the complexities of product development and market valuation.
Transcript
Play full episode
